Valeur202020212022202320242025TTMFrais de vente, généraux et administratifs283.95 M302.58 M608.35 M606.69 M638.76 M625.21 M622.54 MRecherche et développement42.95 M47.5 M92.98 M85.34 M88.61 M87.5 M85.48 MRésultat d'exploitation98.16 M123.25 M-42.9 M22.82 M42.96 M42.83 M43.52 MTotal des produits hors exploitation1.08 M799 K-5.14 M-5.91 M-13.22 M-232 K471 KCharges d'intérêts, nettes des intérêts capitalisés1.75 M858 K70.81 M102.73 M106.54 M93.34 M87.8 MRésultat hors exploitation, hors charges d'intérêts-668 K-59 K-75.94 M-108.63 M-119.76 M-93.57 M-87.33 MRevenus/dépenses exceptionnels———————Résultat avant impôts97.49 M123.19 M-114.41 M-78.3 M-66.01 M3.17 M29.06 MPart des actionnaires dans le résultat—————-1.19 M-1.8 MImpôts10.62 M20.05 M-40.12 M-48.64 M51.68 M2.44 M-36.85 MIntérêts ne donnant pas le contrôle / intérêts minoritaires———————Autres produits/charges après impôts———————Résultat net avant activités abandonnées86.87 M103.14 M-74.29 M-29.66 M-117.69 M732 K46.34 MActivités abandonnées———————Résultat net86.87 M103.14 M-74.29 M-29.66 M-117.69 M732 K46.34 MAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires86.87 M103.14 M-74.29 M-29.66 M-117.69 M732 K46.34 MBénéfice par action de base (BPA de base)4.164.86-3.11-1.23-4.830.031.88Bénéfice par action dilué (BPA dilué)4.024.74-3.11-1.23-4.830.031.86Nombre moyen d'actions de base en circulation20.91 M21.21 M23.87 M24.09 M24.39 M24.64 M—Nombre d'actions en circulation après dilution21.59 M21.78 M23.87 M24.09 M24.39 M24.9 M—EBITDA183.79 M212.94 M192.25 M251.6 M262.48 M243.57 M565.26 MEBIT98.16 M123.25 M-42.9 M22.82 M42.96 M42.83 M363.94 MCoût des ventes809.51 M824.82 M1.58 B1.52 B1.56 B1.41 B1.02 BAutres coûts des ventes2.63 M3.38 M00———Amortissements (flux de trésorerie)85.63 M89.7 M235.15 M228.77 M219.51 M200.74 M201.32 M
ICU Medical, Inc. - Common Stock
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, and hemodynamic monitoring systems.
ICU Medical products are designed to prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. In addition, the company's IV medication compounding and delivery products are designed to improve medication and dosing accuracy and improve clinical workflows. In 2014 ICU Medical was named one of the 100 Most Trustworthy Companies in America by Forbes Magazine.